
NYSEHealthcareMedical - Diagnostics & Research
Latest quote
$603.02
−$10.76 · -1.75%
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
Previous close
$603.02
−$10.76 · -1.75%
Regular session · ET · Market data may be delayed.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
Day range
Current $603.02
52-week range
Current $603.02
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
77
Undervalued
Sentiment
66
Bullish
Risk
32
Moderate Risk
Momentum
53
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
Day range
Current $603.02
52-week range
Current $603.02
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 44.56B USD | 42.88B USD | 42.86B USD | 44.92B USD | 39.21B USD |
| Cost of goods sold | 27.78B USD | 25.15B USD | 25.66B USD | 25.9B USD | 19.58B USD |
| Gross profit | 16.78B USD | 17.73B USD | 17.19B USD | 19.01B USD | 19.63B USD |
| Research and development | 1.4B USD | 1.39B USD | 1.34B USD | 1.47B USD | 1.41B USD |
| Selling, general, and administrative | 7.27B USD | 8.68B USD | 8.41B USD | 9.02B USD | 7.91B USD |
| Operating expenses | 8.67B USD | 10.07B USD | 9.75B USD | 10.49B USD | 9.32B USD |
| Interest income | 993M USD | 1.08B USD | 879M USD | 272M USD | 43M USD |
| Interest expense | 1.42B USD | 1.65B USD | 1.49B USD | 726M USD | 536M USD |
| Depreciation and amortization | 2.78B USD | 3.11B USD | 3.41B USD | 3.38B USD | 2.59B USD |
| Operating income | 8.11B USD | 7.66B USD | 7.45B USD | 8.53B USD | 10.32B USD |
| Net income | 6.74B USD | 6.34B USD | 6B USD | 6.95B USD | 7.73B USD |
Company facts updated Sep 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Cash distributions grouped by calendar year; partial years are marked.
$1.72
2025 complete year+65.4% since 2021
2026 partial: $0.94
$1.04
2,021
$1.20
2,022
$1.40
2,023
$1.56
2,024
$1.72
2,025
$0.94
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 15, 2026 | $0.47Quarterly | Sep 15, 2026 | Oct 15, 2026 |
Dividend | Jun 15, 2026 | $0.47Quarterly | Jun 15, 2026 | Jul 15, 2026 |
Dividend | Mar 13, 2026 | $0.47Quarterly | Mar 13, 2026 | Apr 15, 2026 |
Dividend | Dec 15, 2025 | $0.43Quarterly | Dec 15, 2025 | Jan 15, 2026 |
Dividend | Sep 15, 2025 | $0.43Quarterly | Sep 15, 2025 | Oct 15, 2025 |
Dividend | Jun 13, 2025 | $0.43Quarterly | Jun 13, 2025 | Jul 15, 2025 |
Ex-dividend Sep 15, 2026
$0.47
Quarterly
Record Sep 15, 2026 · Payment Oct 15, 2026
Ex-dividend Jun 15, 2026
$0.47
Quarterly
Record Jun 15, 2026 · Payment Jul 15, 2026
Ex-dividend Mar 13, 2026
$0.47
Quarterly
Record Mar 13, 2026 · Payment Apr 15, 2026
Ex-dividend Dec 15, 2025
$0.43
Quarterly
Record Dec 15, 2025 · Payment Jan 15, 2026
Ex-dividend Sep 15, 2025
$0.43
Quarterly
Record Sep 15, 2025 · Payment Oct 15, 2025
Ex-dividend Jun 13, 2025
$0.43
Quarterly
Record Jun 13, 2025 · Payment Jul 15, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI6.8B0.30%2.3T USD0.03%$377.6-0.56%
Vanguard S&P 500 ETFVOO5.6B0.33%1.7T USD0.03%$704.07-0.56%
iShares Core S&P 500 ETFIVV3.01B0.34%870.63B USD0.03%$769.2-0.61%
State Street SPDR S&P 500 ETFSPY2.8B0.34%812.03B USD0.09%$765.96-0.55%
Vanguard Morningstar Value ETFVTV2.03B0.79%256.5B USD0.03%$224.64-0.80%
State Street Health Care Select Sector SPDR ETFXLV1.66B3.69%44.5B USD0.08%$167.13-2.52%
Vanguard Health Care ETFVHT648.46M3.09%20.9B USD0.09%$314.61-2.19%
State Street SPDR Portfolio S&P 500 ETFSPYM584.65M0.34%169.13B USD0.02%$90.17-0.55%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLV
Vanguard Health Care ETFVHT
State Street SPDR Portfolio S&P 500 ETFSPYMAI-generated and delayed market data for informational and educational purposes only. Not investment advice.